These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25072868)

  • 1. On the risk concerns of zacopride, a moderate IK1 channel agonist with cardiac protective action.
    Wu BW; Cao JM
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):357-9. PubMed ID: 25072868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel discovery of IK1 channel agonist: zacopride selectively enhances IK1 current and suppresses triggered arrhythmias in the rat.
    Liu QH; Li XL; Xu YW; Lin YY; Cao JM; Wu BW
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):37-48. PubMed ID: 21921806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
    Zhai XW; Zhang L; Guo YF; Yang Y; Wang DM; Zhang Y; Li P; Niu YF; Feng QL; Wu BW; Cao JM; Liu QH
    PLoS One; 2017; 12(5):e0177600. PubMed ID: 28542320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction.
    Liu CF; Liu QH; Liu EL; Zhai XW; Zhang L; Luo TE; Zhang WF; Feng QL; Cui XL; Zhao ZQ; Cao JM; Wu BW
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):345-56. PubMed ID: 25286360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zacopride, a moderate I
    Elnakish MT; Canan BD; Kilic A; Mohler PJ; Janssen PM
    Pharmacol Res; 2017 Jan; 115():309-318. PubMed ID: 27914945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I
    Zhai X; Qiao X; Zhang L; Wang D; Zhang L; Feng Q; Wu B; Cao J; Liu Q
    Life Sci; 2019 Dec; 239():117075. PubMed ID: 31751587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes.
    Zhang L; Liu Q; Liu C; Zhai X; Feng Q; Xu R; Cui X; Zhao Z; Cao J; Wu B
    Sci China Life Sci; 2013 Sep; 56(9):788-96. PubMed ID: 23929001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of IK1 by zacopride: amelioration of left ventricular remodeling, but at what risk?
    Curtis MJ
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):343-4. PubMed ID: 25000479
    [No Abstract]   [Full Text] [Related]  

  • 9. Zacopride Exerts an Antiarrhythmic Effect by Specifically Stimulating the Cardiac Inward Rectifier Potassium Current in Rabbits: Exploration of a New Antiarrhythmic Strategy.
    Lin Y; Li J; Zhu B; Liu Q; Bai X; Chang B; Guo Y; Feng Q; Li X; Wu B; Cao J
    Curr Pharm Des; 2020; 26(44):5746-5754. PubMed ID: 32611299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Agonist of Inward Rectifier Potassium Channel (I
    Liu Q; Sun J; Zhang L; Xu Y; Wu B; Cao J
    Int Heart J; 2021; 62(6):1348-1357. PubMed ID: 34853227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Singular Role of I
    Sun Y; Timofeyev V; Dennis A; Bektik E; Wan X; Laurita KR; Deschênes I; Li RA; Fu JD
    Stem Cell Rev Rep; 2017 Oct; 13(5):631-643. PubMed ID: 28623610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening of the inward rectifier potassium channel alleviates maladaptive tissue repair following myocardial infarction.
    Liu C; Liu E; Luo T; Zhang W; He R
    Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):687-95. PubMed ID: 27486024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic upregulation of IK1 in the mouse heart is proarrhythmic.
    Piao L; Li J; McLerie M; Lopatin AN
    Basic Res Cardiol; 2007 Sep; 102(5):416-28. PubMed ID: 17546530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome.
    Meyers NL; Hickling RI
    J Int Med Res; 2007; 35(6):848-66. PubMed ID: 18034998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
    Gómez R; Caballero R; Barana A; Amorós I; De Palm SH; Matamoros M; Núñez M; Pérez-Hernández M; Iriepa I; Tamargo J; Delpón E
    Cardiovasc Res; 2014 Nov; 104(2):337-46. PubMed ID: 25205296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
    Domenighetti AA; Boixel C; Cefai D; Abriel H; Pedrazzini T
    J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The new potassium channel blocker tedisamil and its hemodynamic, anti-ischemic and neurohumoral effect in patients with coronary heart disease].
    Mitrovic V; Oehm E; Strasser R; Schlepper M; Pitschner HF
    Z Kardiol; 1996 Dec; 85(12):961-72. PubMed ID: 9082675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.
    Lengyel C; Dézsi L; Biliczki P; Horváth C; Virág L; Iost N; Németh M; Tálosi L; Papp JG; Varró A
    Br J Pharmacol; 2004 Sep; 143(1):152-8. PubMed ID: 15302678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging trial of zacopride: the emetic antiemetic?
    Pisters KM; Kris MG; Tyson LB; Clark RA; Gralla RJ
    J Natl Cancer Inst; 1992 May; 84(9):717-8. PubMed ID: 1569606
    [No Abstract]   [Full Text] [Related]  

  • 20. Anxiolytic-like activity of R(+)- and S(-)-zacopride in mice.
    Young R; Johnson DN
    Eur J Pharmacol; 1991 Aug; 201(2-3):151-5. PubMed ID: 1686755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.